Hugo Ribeiro Zanetti1,2, Edmar Lacerda Mendes3, Antonio Carlos Palandri Chagas4,5, Maria Odila Gomes Douglas5, Leandro Teixeira Paranhos Lopes6, Leonardo Roever7, Alexandre Gonçalves7,8,9, Elmiro Santos Resende7. 1. Post-Graduate Program in Health Sciences, Faculty of Medicine, Federal University of Uberlândia, Uberlândia, MG, Brazil. hugo.zanetti@hotmail.com. 2. Master Institute of Education President Antônio Carlos, Avenida Minas Gerais, 1889 - Centro, Araguari, MG, 38.440-046, Brazil. hugo.zanetti@hotmail.com. 3. Federal University of Triângulo Mineiro, Uberaba, MG, Brazil. 4. Heart Institute, São Paulo, SP, Brazil. 5. Faculty of Medicine of ABC, São Paulo, SP, Brazil. 6. Brasil University, Fernandópolis, SP, Brazil. 7. Post-Graduate Program in Health Sciences, Faculty of Medicine, Federal University of Uberlândia, Uberlândia, MG, Brazil. 8. Master Institute of Education President Antônio Carlos, Avenida Minas Gerais, 1889 - Centro, Araguari, MG, 38.440-046, Brazil. 9. Atenas Faculty, Paracatu, MG, Brazil.
Abstract
PURPOSE OF REVIEW: This review is focused on cardiovascular risk factors in HIV-infected people. RECENT FINDINGS: Antiretroviral therapy (ART) has significantly increased the life expectancy of HIV-infected people. Thus, this population has experienced non-HIV-related diseases, mainly cardiovascular diseases. Thus, in our review, we intend to understand the cardiovascular risk factors that trigger this situation. We have demonstrated that both ART and traditional cardiovascular risk factors contribute to the development of cardiovascular disease in HIV-infected people. Thus, it becomes important to stratify the risk factors to reduce this scenario.
PURPOSE OF REVIEW: This review is focused on cardiovascular risk factors in HIV-infected people. RECENT FINDINGS: Antiretroviral therapy (ART) has significantly increased the life expectancy of HIV-infected people. Thus, this population has experienced non-HIV-related diseases, mainly cardiovascular diseases. Thus, in our review, we intend to understand the cardiovascular risk factors that trigger this situation. We have demonstrated that both ART and traditional cardiovascular risk factors contribute to the development of cardiovascular disease in HIV-infected people. Thus, it becomes important to stratify the risk factors to reduce this scenario.
Authors: Roopinder K Sandhu; Monik C Jimenez; Stephanie E Chiuve; Kathryn C Fitzgerald; Stacey A Kenfield; Usha B Tedrow; Christine M Albert Journal: Circ Arrhythm Electrophysiol Date: 2012-12-11
Authors: Katherine Krauskopf; Mark L Van Natta; Ronald P Danis; Sapna Gangaputra; Lori Ackatz; Adrienne Addessi; Alex D Federman; Andrea D Branch; Curtis L Meinert; Douglas A Jabs Journal: J Int Assoc Provid AIDS Care Date: 2013 Sep-Oct
Authors: Monica Malta; Cosme M F P da Silva; Monica Mf Magnanini; Andrea L Wirtz; André R S Perissé; Chris Beyrer; Steffanie A Strathdee; Francisco I Bastos Journal: BMC Public Health Date: 2015-03-07 Impact factor: 3.295